Trial Profile
Open study to evaluate treatment with taxotere, cisplatin and capecitabine (TCX) in patients with advanced gastric cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2016
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 29 Aug 2011 New trial record